Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Single-Cell Analysis | 5 | 2022 | 2413 | 0.230 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2022 | 162 | 0.180 |
Why?
|
| Optic Lobe, Nonmammalian | 1 | 2019 | 12 | 0.170 |
Why?
|
| Epidermal Growth Factor | 1 | 2022 | 700 | 0.170 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2023 | 2468 | 0.160 |
Why?
|
| Palatine Tonsil | 1 | 2019 | 193 | 0.160 |
Why?
|
| Staining and Labeling | 2 | 2022 | 1083 | 0.160 |
Why?
|
| Naphthyridines | 1 | 2019 | 143 | 0.160 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2023 | 8967 | 0.160 |
Why?
|
| Ribulose-Bisphosphate Carboxylase | 1 | 2017 | 18 | 0.150 |
Why?
|
| Azepines | 1 | 2019 | 329 | 0.150 |
Why?
|
| Mammals | 1 | 2022 | 1132 | 0.140 |
Why?
|
| Cell Nucleus | 2 | 2022 | 2906 | 0.140 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2022 | 819 | 0.130 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2019 | 2509 | 0.130 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2017 | 171 | 0.130 |
Why?
|
| Immunoglobulins | 1 | 2019 | 859 | 0.130 |
Why?
|
| Heat-Shock Proteins | 1 | 2020 | 795 | 0.130 |
Why?
|
| Oxazepines | 1 | 2015 | 22 | 0.130 |
Why?
|
| Enzyme Inhibitors | 2 | 2017 | 3710 | 0.130 |
Why?
|
| Peptides, Cyclic | 1 | 2017 | 392 | 0.120 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2015 | 150 | 0.120 |
Why?
|
| Drug Discovery | 1 | 2022 | 1054 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 2 | 2019 | 2647 | 0.120 |
Why?
|
| Software | 3 | 2022 | 4426 | 0.110 |
Why?
|
| Adaptation, Physiological | 1 | 2020 | 1301 | 0.110 |
Why?
|
| Neoplasms | 4 | 2023 | 22083 | 0.100 |
Why?
|
| Melanoma | 2 | 2022 | 5704 | 0.100 |
Why?
|
| Microscopy | 3 | 2022 | 886 | 0.100 |
Why?
|
| Indoles | 1 | 2019 | 1833 | 0.100 |
Why?
|
| Skin Neoplasms | 2 | 2022 | 5815 | 0.100 |
Why?
|
| Antibodies | 1 | 2019 | 2421 | 0.090 |
Why?
|
| Apoptosis | 3 | 2021 | 9468 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2019 | 2860 | 0.090 |
Why?
|
| Drosophila Proteins | 1 | 2019 | 1698 | 0.090 |
Why?
|
| Synapses | 1 | 2019 | 1762 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 2870 | 0.080 |
Why?
|
| Proteomics | 1 | 2022 | 3818 | 0.080 |
Why?
|
| Tumor Microenvironment | 4 | 2023 | 3874 | 0.080 |
Why?
|
| Glioma | 1 | 2022 | 3434 | 0.070 |
Why?
|
| Glioblastoma | 1 | 2022 | 3481 | 0.070 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11729 | 0.070 |
Why?
|
| Ovarian Neoplasms | 2 | 2020 | 4879 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 11070 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 9410 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2023 | 6330 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 5292 | 0.060 |
Why?
|
| Proteins | 1 | 2019 | 6033 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 8519 | 0.060 |
Why?
|
| Genomics | 1 | 2019 | 5806 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 6894 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2019 | 7849 | 0.050 |
Why?
|
| Animals | 7 | 2022 | 168253 | 0.050 |
Why?
|
| Cell Line, Tumor | 4 | 2020 | 16945 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 9267 | 0.050 |
Why?
|
| Cell Survival | 2 | 2022 | 5790 | 0.050 |
Why?
|
| 5'-Nucleotidase | 1 | 2022 | 161 | 0.050 |
Why?
|
| Fluorescent Dyes | 2 | 2019 | 1900 | 0.050 |
Why?
|
| Atlases as Topic | 1 | 2022 | 247 | 0.050 |
Why?
|
| Humans | 19 | 2023 | 760437 | 0.050 |
Why?
|
| Vero Cells | 1 | 2021 | 482 | 0.040 |
Why?
|
| Phase Transition | 1 | 2020 | 71 | 0.040 |
Why?
|
| Neurons | 1 | 2019 | 9443 | 0.040 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2015 | 3610 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 13616 | 0.040 |
Why?
|
| raf Kinases | 1 | 2019 | 118 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 3590 | 0.040 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2019 | 122 | 0.040 |
Why?
|
| Heat-Shock Response | 1 | 2020 | 179 | 0.040 |
Why?
|
| Paraffin Embedding | 1 | 2019 | 302 | 0.040 |
Why?
|
| Tissue Fixation | 1 | 2019 | 241 | 0.040 |
Why?
|
| Lung Neoplasms | 2 | 2020 | 13312 | 0.040 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2019 | 132 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2022 | 828 | 0.040 |
Why?
|
| Diagnostic Imaging | 2 | 2023 | 3541 | 0.040 |
Why?
|
| Indazoles | 1 | 2020 | 302 | 0.040 |
Why?
|
| Formaldehyde | 1 | 2019 | 358 | 0.040 |
Why?
|
| Heart Failure | 1 | 2022 | 11653 | 0.040 |
Why?
|
| Ecosystem | 1 | 2022 | 489 | 0.040 |
Why?
|
| Color | 1 | 2019 | 299 | 0.040 |
Why?
|
| Carbon Cycle | 1 | 2017 | 15 | 0.040 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2019 | 473 | 0.040 |
Why?
|
| Synechococcus | 1 | 2017 | 30 | 0.040 |
Why?
|
| Virus Internalization | 1 | 2021 | 496 | 0.040 |
Why?
|
| Adenosine | 1 | 2022 | 804 | 0.040 |
Why?
|
| Cyanobacteria | 1 | 2017 | 52 | 0.040 |
Why?
|
| Molecular Probes | 1 | 2019 | 310 | 0.040 |
Why?
|
| Oncogenes | 1 | 2023 | 1223 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2019 | 641 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2022 | 934 | 0.030 |
Why?
|
| Interferons | 1 | 2020 | 704 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2017 | 465 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2020 | 4575 | 0.030 |
Why?
|
| Interferon Type I | 1 | 2019 | 562 | 0.030 |
Why?
|
| Ligands | 1 | 2022 | 3270 | 0.030 |
Why?
|
| Ovary | 1 | 2020 | 958 | 0.030 |
Why?
|
| Organelles | 1 | 2017 | 266 | 0.030 |
Why?
|
| Gene Amplification | 1 | 2020 | 1086 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 1610 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2019 | 1561 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 1089 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2020 | 961 | 0.030 |
Why?
|
| Data Collection | 1 | 2022 | 3321 | 0.030 |
Why?
|
| Carbon Dioxide | 1 | 2017 | 1146 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2017 | 1792 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2017 | 1697 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2017 | 1982 | 0.030 |
Why?
|
| Mice | 4 | 2021 | 81402 | 0.020 |
Why?
|
| Signal Transduction | 3 | 2020 | 23397 | 0.020 |
Why?
|
| Protein Transport | 1 | 2017 | 1965 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2017 | 3075 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2015 | 1755 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2020 | 4108 | 0.020 |
Why?
|
| Piperidines | 1 | 2020 | 1656 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 2453 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2019 | 2058 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 2018 | 1994 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2019 | 1709 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2022 | 3815 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2017 | 2189 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2018 | 1588 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2015 | 2215 | 0.020 |
Why?
|
| Algorithms | 2 | 2019 | 14002 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 3792 | 0.020 |
Why?
|
| Retina | 1 | 2019 | 2652 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2020 | 2529 | 0.020 |
Why?
|
| Cytokines | 1 | 2022 | 7377 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 7597 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2021 | 18955 | 0.020 |
Why?
|
| DNA | 1 | 2019 | 7208 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2015 | 5427 | 0.020 |
Why?
|
| Cell Line | 1 | 2019 | 15598 | 0.020 |
Why?
|
| Macrophages | 1 | 2020 | 5764 | 0.020 |
Why?
|
| Phenotype | 1 | 2022 | 16585 | 0.010 |
Why?
|
| Age Factors | 1 | 2021 | 18379 | 0.010 |
Why?
|
| Female | 5 | 2021 | 391875 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2017 | 3842 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2019 | 10425 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2015 | 13445 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 15820 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 5662 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 22121 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 17639 | 0.010 |
Why?
|
| Lung | 1 | 2021 | 9973 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2020 | 11526 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 2020 | 5143 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 20078 | 0.010 |
Why?
|
| Infant | 1 | 2021 | 36183 | 0.010 |
Why?
|
| Aged | 2 | 2021 | 168840 | 0.010 |
Why?
|
| Middle Aged | 2 | 2021 | 220382 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 58859 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2023 | 80430 | 0.010 |
Why?
|
| Child | 1 | 2022 | 80086 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2020 | 64591 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 20985 | 0.010 |
Why?
|
| Male | 1 | 2021 | 360035 | 0.000 |
Why?
|
Concepts
(156)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(61)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_